Redefining medicine through cannabinoid innovation.
Advantage
GMP produces common & rare cannabinoids
These cannabinoids can be used as Active Pharmaceutical Ingredients (API’s).
View ProductsINNOVATION
LOW COSTS
SPEED-TO-SALE
Building Intrinsic Value
GMP provides more value to its customers than any other LP
Our ability to super produce pharma-grade API’s allows us to provide the following:
- Lower purchasing costs for bulk API’s and finished products
- Higher purity of cannabinoids (pharma-grade)
- Greater bio-availability due to nano-suspended production
- Rare cannabinoids that open vast medicinal R&D possibilities
Production Capabilities
State-of-the-art facility
Our Toronto based state-of-the-art 100,000 sq. ft. facility can produce enough semi-synthetic cannabinoids to concurrently satisfy the following production needs:
Product Portfolio
Patented Intellectual Property
Our R&D lab, led by our experienced product development team has perfected several different proprietary nano-suspended formulas that will be first-to-market in the Cannabis landscape. From fine-mist sublingual sprays to nebulizer formulas to IV drips, our team is ensuring ground-breaking formulas and perfect dosing methods for an array of medicinal relief.
